Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
102.78%
0%
102.78%
1 Year
52.95%
0%
52.95%
2 Years
41.98%
0%
41.98%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Dipna Pharmachem for the last several years.
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
74.40%
EBIT Growth (5y)
59.00%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
33
Price to Book Value
1.02
EV to EBIT
12.84
EV to EBITDA
12.77
EV to Capital Employed
1.02
EV to Sales
0.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.91%
ROE (Latest)
2.91%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Keyur Dipakkumar Shah (9.97%)
Highest Public shareholder
Sunita Santosh Goenka (2.34%)
Individual Investors Holdings
81.82%
Half Yearly Results Snapshot (Standalone) - Mar'24
Mar'24
Sep'23
Change(%)
Net Sales
90.31
74.03
21.99%
Operating Profit (PBDIT) excl Other Income
1.76
1.68
4.76%
Interest
1.13
0.87
29.89%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.49
0.59
-16.95%
Operating Profit Margin (Excl OI)
1.95%
2.27%
-0.32%
Values in Rs Cr.
Net Sales
Growth in half year ended Mar 2024 is 21.99% vs 44.25% in Sep 2023
Standalone Net Profit
Growth in half year ended Mar 2024 is -16.95% vs 1.72% in Sep 2023
Annual Results Snapshot (Standalone) - Mar'24
Mar'24
Mar'23
Change(%)
Net Sales
164.34
99.93
64.46%
Operating Profit (PBDIT) excl Other Income
3.43
2.35
45.96%
Interest
2.00
0.96
108.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.09
0.91
19.78%
Operating Profit Margin (Excl OI)
2.09%
2.35%
-0.26%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2024 is 64.46% vs -86.27% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 19.78% vs -92.20% in Mar 2023
About Dipna Pharmachem Ltd 
Dipna Pharmachem Ltd
Micro Cap
Pharmaceuticals & Drugs
Dipan Pharmachem Private Limited was incorporated on July 19, 2011. Subsequently, the Company name was changed to "Dipna Pharmachem Private Limited" on March 29, 2012. Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to "Dipna Pharmachem Limited" vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr.
Company Coordinates 
No Company Details Available